Massar Alsamraae, PhD

Department Affiliations
Postdoctoral Trainee, Cook Lab

Education and Training
BS, Veterinary Medicine and Surgery/ Al Qadissiyia University, Iraq, 2003
MSC Internal and Preventive Medicine / Al Qadissiyia University, Iraq, 2011
PhD Molecular genetic/ Cancer biology/ Newcastle University / NICR, United Kingdom

Notable Publications
Neutrophils are mediators of metastatic prostate cancer progression in bone. Costanzo-Garvey, D.L., Keeley, T., Case, A.J., Watson, G.F., Alsamraae, M., Yu, Y., Su, K., Heim, C.E., Kielian, T., Morrissey, C. and Frieling, J.S., 2020.. Cancer Immunology, Immunotherapy, pp.1-18.

Abstract 316: Identification of SGK1 as a potential therapeutic target in castrate resistance prostate cancer. Massar I. Alsamraae, Urzsula McClurg, Craig N. Robson and Stuart McCracken. DOI: 10.1158/1538-445.AM2017-316 Published July 2017

Abnormal HER2 and HER3 Signalling in Prostate Cancer: Potentials for Clinical Applications. Kasturi Rao, Massar Alsamraae, Luke Gaughan, Craig Robson, Stuart McCracken, Newcastle upon Tyne, United Kingdom. THE JOURNAL OF UROLOGY. Vol. 195, No. 4S, Supplement, Sunday, May 8, 2016

The role of the HER2 and HER3 in prostate cancer and their potential as therapeutic targets. Rao K., Alsamraae M., Gaughan L., Robson C., McCracken S. Newcastle University, Northern Institute for Cancer Research, Newcastle upon Tyne, United Kingdom. Eur Urol Suppl 2016;15(3);e41